Gufic Biosciences Limited (BOM:509079)
India
· Delayed Price · Currency is INR 373.50
+3.50 (0.95%)
At close: Jun 10, 2025
Gufic Biosciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Cash & Equivalents | 290.22 | 11.37 | 286.02 | 116.08 | 62.01 | Upgrade
|
| Cash & Short-Term Investments | 290.22 | 11.37 | 286.02 | 116.08 | 62.01 | Upgrade
|
| Cash Growth | 2452.97% | -96.03% | 146.40% | 87.18% | 45.52% | Upgrade
|
| Accounts Receivable | 3,146 | 3,299 | 2,055 | 1,516 | 1,245 | Upgrade
|
| Other Receivables | 15.71 | - | - | - | - | Upgrade
|
| Receivables | 3,165 | 3,303 | 2,057 | 1,519 | 1,248 | Upgrade
|
| Inventory | 2,169 | 2,005 | 1,835 | 1,156 | 944.05 | Upgrade
|
| Prepaid Expenses | - | 8.61 | 9.5 | 8.51 | 5.8 | Upgrade
|
| Other Current Assets | 621.32 | 676.9 | 454.29 | 407.93 | 346.43 | Upgrade
|
| Total Current Assets | 6,245 | 6,005 | 4,641 | 3,208 | 2,606 | Upgrade
|
| Property, Plant & Equipment | 5,215 | 4,603 | 3,285 | 1,554 | 1,129 | Upgrade
|
| Long-Term Investments | 17.84 | 17.84 | 7.84 | 0.08 | 0.08 | Upgrade
|
| Other Intangible Assets | 63.44 | 56.19 | 6.79 | 6.1 | 4.45 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | 9.66 | - | - | Upgrade
|
| Other Long-Term Assets | 150.33 | 239.13 | 658.02 | 443.58 | 178.1 | Upgrade
|
| Total Assets | 11,694 | 10,925 | 8,612 | 5,214 | 3,921 | Upgrade
|
| Accounts Payable | 1,587 | 1,663 | 1,303 | 1,410 | 1,112 | Upgrade
|
| Accrued Expenses | - | 184.07 | 143.78 | 172.45 | 191.99 | Upgrade
|
| Short-Term Debt | - | - | 1,118 | 65.99 | 163.24 | Upgrade
|
| Current Portion of Long-Term Debt | 1,799 | 1,631 | 89.67 | 66.65 | 35.98 | Upgrade
|
| Current Portion of Leases | 62.27 | 43.26 | 65.76 | 28.17 | 33.66 | Upgrade
|
| Current Income Taxes Payable | - | 25.45 | 31.24 | 6.75 | 15.82 | Upgrade
|
| Other Current Liabilities | 427.06 | 174.31 | 131.37 | 114.5 | 83.79 | Upgrade
|
| Total Current Liabilities | 3,876 | 3,720 | 2,882 | 1,864 | 1,637 | Upgrade
|
| Long-Term Debt | 1,305 | 1,540 | 1,907 | 479.78 | 354.27 | Upgrade
|
| Long-Term Leases | 195.93 | 115.55 | 162.1 | 3.29 | 28.22 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 77.72 | 20.63 | - | 1.9 | 14.9 | Upgrade
|
| Other Long-Term Liabilities | 228.65 | 112.92 | 104.8 | 107.98 | 100.9 | Upgrade
|
| Total Liabilities | 5,683 | 5,600 | 5,134 | 2,523 | 2,186 | Upgrade
|
| Common Stock | 100.28 | 100.28 | 96.95 | 96.95 | 96.95 | Upgrade
|
| Additional Paid-In Capital | - | 996.57 | - | - | - | Upgrade
|
| Retained Earnings | - | 3,538 | 2,686 | 1,899 | 950.31 | Upgrade
|
| Comprehensive Income & Other | 5,910 | 690.72 | 694.76 | 695.22 | 687.11 | Upgrade
|
| Shareholders' Equity | 6,011 | 5,326 | 3,478 | 2,691 | 1,734 | Upgrade
|
| Total Liabilities & Equity | 11,694 | 10,925 | 8,612 | 5,214 | 3,921 | Upgrade
|
| Total Debt | 3,362 | 3,329 | 3,342 | 643.87 | 615.37 | Upgrade
|
| Net Cash (Debt) | -3,072 | -3,318 | -3,056 | -527.79 | -553.36 | Upgrade
|
| Net Cash Per Share | -30.65 | -33.68 | -31.52 | -5.44 | -5.71 | Upgrade
|
| Filing Date Shares Outstanding | 100.25 | 100.28 | 96.94 | 96.94 | 96.94 | Upgrade
|
| Total Common Shares Outstanding | 100.25 | 100.28 | 96.94 | 96.94 | 96.94 | Upgrade
|
| Working Capital | 2,370 | 2,284 | 1,759 | 1,344 | 969.2 | Upgrade
|
| Book Value Per Share | 59.96 | 53.11 | 35.88 | 27.76 | 17.89 | Upgrade
|
| Tangible Book Value | 5,947 | 5,269 | 3,471 | 2,685 | 1,730 | Upgrade
|
| Tangible Book Value Per Share | 59.32 | 52.55 | 35.81 | 27.70 | 17.84 | Upgrade
|
| Land | - | 98.9 | - | - | - | Upgrade
|
| Buildings | - | 383.55 | 417.59 | 355.81 | 235.49 | Upgrade
|
| Machinery | - | 1,516 | 1,534 | 1,229 | 1,119 | Upgrade
|
| Construction In Progress | - | 3,071 | 1,696 | 408.74 | 134.01 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.